InsiderTrades

Form 4 for ACET Adicet Bio, Inc.

Accepted 2024-01-26 00:00:00 ET · period of report 2024-01-24 · accession 0000950170-24-008049 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-01-26 2024-01-24 ACET Healey Don CTO A - Grant $0.00 +19.7K 72.3K +37% $0
D 2024-01-26 2024-01-24 ACET Healey Don CTO F - Tax $2.40 -4,870 52.6K -8% -$11.7K
D 2024-01-26 2024-01-24 ACET Healey Don CTO A - Grant $0.00 +211.6K 211.6K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-01-24 A A 19,700 $0.00 72,329 D — — (F2) The Reporting Person was issued RSUs. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest in three (3) annual installments, with the first tranche vesting on January 24, 2025. The RSUs may be settled only by delivering shares of Common Stock, and thus, the grant is being reported in Table I as allowed per SEC guidance.
2 Common Common Stock 2024-01-24 F D 4,870 $2.40 52,629 D — —
3 Derivative Stock Option (Right to Buy) 2024-01-24 A A 211,633 $0.00 211,633 D $2.40 · — to 2034-01-23 211,633 Common Stock (F3) 1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of the grant date, provided that the Reporting Person maintains a service relationship with the Issuer as of the applicable vesting dates.